C. A. Rodriguez

发表

Perspectives for the structure-based design of acetylcholinesterase reactivators.

R. Ochoa, C. A. Rodriguez, Andres F Zuluaga, 2016, Journal of molecular graphics & modelling.

Prediction of Ligands Binding Acetylcholinesterase with Potential Antidotal Activity: A Virtual Screening Approach

R. Ochoa, C. A. Rodriguez, Andres F Zuluaga, 2019, Molecular informatics.

Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2010, PloS one.

Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2016, PloS one.

Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2019, PloS one.

Nonparametric Population Pharmacokinetic Modeling of Isoniazid in Colombian Patients With Tuberculosis.

M. Neely, C. A. Rodriguez, Andres F Zuluaga, 2019, Therapeutic drug monitoring.

Influence of the unbound concentration of cefonicid on its renal elimination in isolated perfused rat kidneys

C. A. Rodriguez, D. Smith, C. Rodriguez, 1991, Antimicrobial Agents and Chemotherapy.

A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2020, PloS one.

Population Pharmacokinetic Models of Anti-Tuberculosis Drugs in Patients: a Systematic Critical Review.

C. A. Rodriguez, Andres F Zuluaga, J. D. Otalvaro, 2020, Therapeutic drug monitoring.

Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.

C. A. Rodriguez, Andres F Zuluaga, O. Vesga, 2015, International journal of antimicrobial agents.

Which is the Pharmacodynamic Target to Calculate a Rational Dose against SARS-Cov-2?

C. A. Rodriguez, Andres F Zuluaga, María A Montoya-Giraldo, 2020 .

[Vancomycin-resistant Staphylococcus aureus].

C. A. Rodriguez, O. Vesga, C. Rodriguez, 2005, Biomedica : revista del Instituto Nacional de Salud.

Antifungal pharmacodynamics: Latin America's perspective

C. A. Rodriguez, Andres F Zuluaga, Javier M. González, 2016, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Pharmacokinetics and Renal Effects of Cidofovir with a Reduced Dose of Probenecid in HIV‐Infected Patients with Cytomegalovirus Retinitis

C. A. Rodriguez, D. Nickens, M. Mucci, 2003, Journal of clinical pharmacology.

Increased kidney glucose utilization induced by cyclosporine: lack of relation to magnesium excretion.

J. Borowitz, C. A. Rodriguez, P. Mayer, 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.